Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Kaname Oka"'
Autor:
Yasuko Hirai, Yuji Naito, Tomohisa Takagi, Yoshito Itoh, Kaname Oka, Takayuki Ota, Takeshi Ishikawa, Toshifumi Doi, Yuki Endo, Kazuhiro Kamada, Hideyuki Konishi, Katsura Mizushima, Juichirou Yoshida, Shinya Matsumura, Ken Inoue, Tetsuya Okayama, Kazuhiko Uchiyama, Tomoki Sakakida
Publikováno v:
Journal of Clinical Biochemistry and Nutrition
Although extensive evidence indicates that the gut microbiota plays a crucial role in regulating glucose homeostasis, the exact regulatory mechanism remains unclear. This study aimed to investigate the effect of broad-spectrum antibiotics on the expr
Autor:
Yuki Endo, Takeshi Ishikawa, Kaname Oka, Tomoki Sakakida, Shinya Matsumura, Katsura Mizushima, Toshifumi Doi, Tetsuya Okayama, Kazuhiro Katada, Kazuhiro Kamada, Kazuhiko Uchiyama, Tomohisa Takagi, Hitoshi Fujiwara, Hideyuki Konishi, Yuji Naito, Yoshito Itoh
Publikováno v:
Medical Oncology. 39
Granulocyte-colony stimulating factor (G-CSF) stimulates bone marrow progenitor cell proliferation and enhances neutrophil production. Exogenous G-CSF administration is indicated for chemotherapy-induced neutropenia management. However, there is a pa
Autor:
Juichiro Yoshida, Yoshito Itoh, Kaname Oka, Katsura Mizushima, Naoyuki Sakamoto, Kazuhiro Kamada, Tomohisa Takagi, Yuji Naito, Yuki Endo, Ken Inoue, Takayuki Ota, Tetsuya Okayama, Kazuhiko Uchiyama, Takeshi Ishikawa, Shinya Matsumura, Yasuko Hirai
Publikováno v:
Oncology Reports. 44:371-381
Epithelial‑mesenchymal transition (EMT) is considered a crucial event in the development of cancer metastasis. Metformin is a drug used in the treatment of type 2 diabetes. Recently, increasing evidence has indicated that metformin possesses anti
Autor:
Mariko Ushioda, Hironao Numabe, Hideaki Sawai, Gen Nishimura, Takashi Omori, Kaname Oka, Shinji Kosugi
Publikováno v:
Pediatrics International
Background Thanatophoric dysplasia (TD) is a rare congenital disease of the skeletal system, with an incidence of 1.68–8.3 per 100 000 births, but statistical data on the estimated number of TD patients across Japan are not available. The aim of th
Autor:
Junichi Mineno, Yoshito Itoh, Hideyuki Konishi, Naoyuki Sakamoto, Kaname Oka, Kazuhiro Kamada, Mitsuko Ideno, Kazuhiko Uchiyama, Tomohisa Takagi, Kazuhiro Katada, Satoshi Kokura, Tatsuji Enoki, Osamu Handa, Kazuko Uno, Naohisa Yoshida, Tetsuya Okayama, Takeshi Ishikawa, Yuji Naito
Publikováno v:
International Journal of Cancer. 142:2599-2609
Natural killer (NK) cells exhibit strong cytotoxic activity against tumor cells without prior sensitization, and have the potential to exert antibody-dependent cellular cytotoxicity (ADCC). In this clinical trial, we examined the safety and efficacy
Autor:
Takeshi Ishikawa, Tetsuya Okayama, Satoshi Kokura, Osamu Handa, Yuji Naito, Manabu Okajima, Yoshito Itoh, Tatsuzo Matsuyama, Kazuhiro Katada, Kaname Oka, Hiromi Sakai, Naoyuki Sakamoto, Reiko Kimura, Kazuhiko Uchiyama, Tomohisa Takagi, Kazuhiro Kamada, Satoko Adachi, Katsura Mizushima
Publikováno v:
International Journal of Cancer. 137:2558-2565
The phenotype and severity of cancer cachexia differ among tumor types and metastatic site in individual patients. In this study, we evaluated if differences in tumor microenvironment would affect the development of cancer cachexia in a murine model,
Autor:
Takeshi, Ishikawa, Tetsuya, Okayama, Naoyuki, Sakamoto, Mitsuko, Ideno, Kaname, Oka, Tatsuji, Enoki, Junichi, Mineno, Naohisa, Yoshida, Kazuhiro, Katada, Kazuhiro, Kamada, Kazuhiko, Uchiyama, Osamu, Handa, Tomohisa, Takagi, Hideyuki, Konishi, Satoshi, Kokura, Kazuko, Uno, Yuji, Naito, Yoshito, Itoh
Publikováno v:
International journal of cancer. 142(12)
Natural killer (NK) cells exhibit strong cytotoxic activity against tumor cells without prior sensitization, and have the potential to exert antibody-dependent cellular cytotoxicity (ADCC). In this clinical trial, we examined the safety and efficacy
Autor:
Kazuhiko Uchiyama, Kazuhiro Kamada, Yuji Naito, Tomoyo Yasuda, Takeshi Ishikawa, Kazuhiro Katada, Toshifumi Doi, Naoyuki Sakamoto, Katsura Mizushima, Kaname Oka, Tetsuya Okayama, Yoshito Itoh, Tomohisa Takagi, Osamu Handa
Publikováno v:
Oncology reports. 37(3)
Although improvements in the chemotherapy modalities for pancreatic cancer have been realized, pancreatic cancer remains one of the most lethal malignancies. New-generation cancer immunotherapy methods, such as blocking of the PD-1/PD-L1 pathway, are
Autor:
Mitsuko Ideno, Naoyuki Sakamoto, Takeshi Ishikawa, Tatsuji Enoki, Yoshito Itoh, Satoshi Kokura, Hideyuki Konishi, Yuji Naito, Kaname Oka, Tetsuya Okayama, Junichi Mineno
Publikováno v:
Cancer Research. 78:CT147-CT147
Background; Natural killer (NK) cells exhibit strong cytotoxic activity against tumor cells, and produce numerous cytokines resulting in the activation of the adoptive immune systems. Thus, NK cell is considered ideal cell for adoptive cancer immunot
Autor:
Yoshito Itoh, Akiko Kato, Tatsuji Enoki, Kaname Oka, Tetsuya Okayama, Junichi Mineno, Toshikazu Yoshikawa, Mitsuko Ideno, Yuji Naito, Naoyuki Sakamoto, Satoshi Kokura, Takeshi Ishikawa, Masashige Tanabe, Fumiyo Sakai
Publikováno v:
Journal of Translational Medicine
Background NK cells can destroy tumor cells without prior sensitization or immunization. Tumors often lose expression of MHC molecules and/or antigens. However, NK cells can lyse tumor cells in a non-MHC-restricted manner and independent of the expre